Recognizing and Managing MCI: Exploring Alzheimer’s Disease, Biomarkers, and Therapeutic Advances

Описание к видео Recognizing and Managing MCI: Exploring Alzheimer’s Disease, Biomarkers, and Therapeutic Advances

This webinar aims to equip healthcare providers with the skills and knowledge to confidently diagnose Mild Cognitive Impairment (MCI) due to Alzheimer's disease, explore treatment options, and effectively monitor patient progress. Attendees will also learn about the latest biomarker testing available in research to help confirm Alzheimer’s disease pathology and gain insights into the emerging treatment options available in Canada.

Комментарии

Информация по комментариям в разработке